Lorna Jane, an Australian activewear company, was recently fined AU$5 million after claiming that its new line of active clothing can stop the spread of COVID-19. The firm said that its clothing could eliminate the virus, thus preventing its spread.
According to BBC News, Lorna Jane released advertisements that say it is using a groundbreaking technology called LJ Shield for its clothing line. It was claimed that this could stop the "transfer of all pathogens."
What the court says on Lorna Jane’s claims
Based on the report, a judge said in a ruling that the company’s claim about LJ Shield is "exploitative, predatory and potentially dangerous." The legal action against Lorna Jane was filed by the Australian Competition & Consumer Commission (ACCC) after the firm started selling its clothing in July amid the COVID-19 pandemic.
The verdict was said to have been released by the federal court on Friday, July 23. The judge said that based on investigations, Lorna Jane has been telling the consumers it has a “reasonable scientific or technological basis" for its claims about its clothing with the LJ Shield.
However, the judge said there was actually no scientific basis for such a claim. For this false and misleading representation to the public, the court slapped the company with a hefty fine.
"This was dreadful conduct as it involved making serious claims regarding public health when there was no basis for them," chairman of the ACCC, Rod Sims, said. "The whole marketing campaign was based upon consumers' desire for greater protection against the global pandemic."
Lorna Jane accepts the judge’s decision
The company was said to have accepted the verdict but explained, it was also misled by its supplier. Lorna Jane claimed its supplier sold them a product that did not deliver what it claimed to be, and they are referring to what they called the LJ Shield technology that is supposed to be anti-viral and anti-bacterial.
Meanwhile, it was learned that this is not the first time that Lorna Jane was fined. As per The Guardian, just in July 2020, the company was fined $40,000 for its failure to seek proper approval for ads from the Therapeutic Goods Administration. As for this new issue, the company issued an apology for its customers while continuing to blame its supplier for the issue.


Ecuador Raises Tariffs on Colombian Imports to 50% Amid Border Security Dispute
Netflix Declines to Raise Bid for Warner Bros. Discovery Amid Competing Paramount Skydance Offer
AWS Data Center in UAE Hit by Fire After Objects Strike Facility Amid Regional Tensions
Trump Warns Iran as Gulf Conflict Disrupts Oil Markets and Global Trade
Gold Prices Surge Over 2% After U.S.-Israel Strikes on Iran Spark Safe-Haven Demand
Japan Manufacturing PMI Jumps to Four-Year High as Global Demand Strengthens
Panama Investigates CK Hutchison’s Port Unit After Court Voids Canal Contracts
USITC to Review Impact of Revoking China’s PNTR Status, Potentially Raising Tariffs on Chinese Imports
Hyundai Motor Group to Invest $6.26 Billion in AI Data Center, Robotics and Renewable Energy Projects in South Korea
Gold Prices Steady in Asia, Set for Strong February Gains on Safe-Haven Demand
Trump Media Weighs Truth Social Spin-Off Amid $6B Fusion Energy Pivot
OpenAI Pentagon AI Contract Adds Safeguards Amid Anthropic Dispute
Australia Targets AI Platforms With Strict Age Verification Rules
Wall Street Futures Tumble as U.S.-Iran Conflict Escalates and Oil Prices Surge
Samsung and SK Hynix Shares Hit Record Highs as Nvidia Earnings Boost AI Chip Demand
Oil Prices Surge 13% as U.S.-Israel Strikes on Iran Spark Supply Fears
Asian Stocks Rise on Nvidia Earnings Boost; Yen Weakens as BOJ Rate Outlook Clouds 



